Skip to main content

Shimadzu Establishes Taiwan Operations

NEW YORK (GenomeWeb News) – Shimadzu recently announced the creation of a wholly owned sales company in Taiwan to increase its presence there.

The new firm called Shimadzu Scientific Instruments, or SST, officially launches on April 8 and will sell Shimadzu instruments directly into the Taiwanese market. Shimadzu had previously offered its products in that market through local distributors.

The operations will be based in Taipei and will have 13 employees in its first fiscal year.

SST will have an application laboratory equipped with mass spectrometers, high-performance liquid chromatography systems, and other analytical and measurement instruments. Using its platforms, the company will develop and "propose on-target analytical methods" for customer needs.

The goal, Shimadzu said, is to increase sales in Taiwan to $13 million by 2017 from $4.5 million in 2012, it said.

The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.